Ming Chen1, Bing Yi1, Ni Zhu1, Xin Wei1, Guan-Xin Zhang2, Shengdong Huang3, Jianxin Sun4. 1. Center for Translational Medicine, Thomas Jefferson University, 1020 Locust Street, Room 286G, Philadelphia, PA 19107, USA. 2. Center for Translational Medicine, Thomas Jefferson University, 1020 Locust Street, Room 286G, Philadelphia, PA 19107, USA The Institute of Cardiothoracic Surgery, Changhai Hospital, Second Military Medical University, Shanghai 200433, China. 3. The Institute of Cardiothoracic Surgery, Changhai Hospital, Second Military Medical University, Shanghai 200433, China. 4. Center for Translational Medicine, Thomas Jefferson University, 1020 Locust Street, Room 286G, Philadelphia, PA 19107, USA The Institute of Cardiothoracic Surgery, Changhai Hospital, Second Military Medical University, Shanghai 200433, China jianxin.sun@jefferson.edu.
Abstract
AIMS: Posttranslational modification, such as phosphorylation, plays an essential role in regulating activation of endothelial NO synthase (eNOS). In the present study, we aim to determine whether eNOS could be phosphorylated and regulated by a novel serine/threonine-protein kinase Pim1 in vascular endothelial cells (ECs). METHODS AND RESULTS: Using immunoprecipitation and protein kinase assays, we demonstrated that Pim1 specifically interacts with eNOS, which leads to a marked phosphorylation of eNOS at Ser-633 and increased production of nitric oxide (NO). Intriguingly, in response to VEGF stimulation, eNOS phosphorylation at Ser-633 exhibits two distinct phases: transient phosphorylation occurring between 0 and 60 min and sustained phosphorylation occurring between 2 and 24 h, which are mediated by the protein kinase A (PKA) and Pim1, respectively. Inhibiting Pim1 by either pharmacological inhibitor SMI-4a or the dominant-negative form of Pim1 markedly attenuates VEGF-induced tube formation, while Pim1 overexpression significantly increases EC tube formation and migration in an NO-dependent manner. Importantly, Pim1 expression and eNOS phosphorylation at Ser-633 were substantially decreased in high glucose-treated ECs and in the aorta of db/db diabetic mice. Increased Pim1 expression ameliorates impaired vascular angiogenesis in diabetic mice, as determined by an ex vivo aortic ring assay. CONCLUSION: Our findings demonstrate Pim1 as a novel kinase that is responsible for the phosphorylation of eNOS at Ser-633 and enhances EC sprouting of aortic rings from diabetic mice, suggesting that Pim1 could potentially serve as a novel therapeutic target for revascularization strategies. Published on behalf of the European Society of Cardiology. All rights reserved.
AIMS: Posttranslational modification, such as phosphorylation, plays an essential role in regulating activation of endothelial NO synthase (eNOS). In the present study, we aim to determine whether eNOS could be phosphorylated and regulated by a novel serine/threonine-protein kinase Pim1 in vascular endothelial cells (ECs). METHODS AND RESULTS: Using immunoprecipitation and protein kinase assays, we demonstrated that Pim1 specifically interacts with eNOS, which leads to a marked phosphorylation of eNOS at Ser-633 and increased production of nitric oxide (NO). Intriguingly, in response to VEGF stimulation, eNOS phosphorylation at Ser-633 exhibits two distinct phases: transient phosphorylation occurring between 0 and 60 min and sustained phosphorylation occurring between 2 and 24 h, which are mediated by the protein kinase A (PKA) and Pim1, respectively. Inhibiting Pim1 by either pharmacological inhibitor SMI-4a or the dominant-negative form of Pim1 markedly attenuates VEGF-induced tube formation, while Pim1 overexpression significantly increases EC tube formation and migration in an NO-dependent manner. Importantly, Pim1 expression and eNOS phosphorylation at Ser-633 were substantially decreased in high glucose-treated ECs and in the aorta of db/db diabeticmice. Increased Pim1 expression ameliorates impaired vascular angiogenesis in diabeticmice, as determined by an ex vivo aortic ring assay. CONCLUSION: Our findings demonstrate Pim1 as a novel kinase that is responsible for the phosphorylation of eNOS at Ser-633 and enhances EC sprouting of aortic rings from diabeticmice, suggesting that Pim1 could potentially serve as a novel therapeutic target for revascularization strategies. Published on behalf of the European Society of Cardiology. All rights reserved.
Authors: Gwynngelle A Borillo; Matt Mason; Pearl Quijada; Mirko Völkers; Christopher Cottage; Michael McGregor; Shabana Din; Kimberlee Fischer; Natalie Gude; Daniele Avitabile; Steven Barlow; Roberto Alvarez; Silvia Truffa; Ross Whittaker; Matthew S Glassy; Asa B Gustafsson; Shigeki Miyamoto; Christopher C Glembotski; Roberta A Gottlieb; Joan Heller Brown; Mark A Sussman Journal: Circ Res Date: 2010-03-04 Impact factor: 17.367
Authors: E Butt; M Bernhardt; A Smolenski; P Kotsonis; L G Fröhlich; A Sickmann; H E Meyer; S M Lohmann; H H Schmidt Journal: J Biol Chem Date: 2000-02-18 Impact factor: 5.157
Authors: D Fulton; J P Gratton; T J McCabe; J Fontana; Y Fujio; K Walsh; T F Franke; A Papapetropoulos; W C Sessa Journal: Nature Date: 1999-06-10 Impact factor: 49.962
Authors: Bo Cen; Ying Xiong; Jin H Song; Sandeep Mahajan; Rachel DuPont; Kristen McEachern; Daniel J DeAngelo; Jorge E Cortes; Mark D Minden; Allen Ebens; Alice Mims; Amanda C LaRue; Andrew S Kraft Journal: Mol Cell Biol Date: 2014-04-28 Impact factor: 4.272
Authors: Andrew Moore; Amol Shindikar; Ingrid Fomison-Nurse; Federica Riu; Pujika E Munasinghe; Thrishila Parshu Ram; Pankaj Saxena; Sean Coffey; Richard W Bunton; Ivor F Galvin; Michael J A Williams; Costanza Emanueli; Paolo Madeddu; Rajesh Katare Journal: Cardiovasc Diabetol Date: 2014-04-01 Impact factor: 9.951